Menu

Zeev Bovan

681 posts

Posts (681)

Zeev Bovan ORCL 3 weeks ago #41

You buy a great company when every one hates it and it at the bottom, be patient hold or accumulate and wait till it becomes the greatest stock on earth, that’s when you sell. $ORCL

Zeev Bovan CRWV 3 weeks ago #42

Speculative stocks will go down to thier true market value and people will call it a “market crash”. Follow the money flow.

Zeev Bovan BABA 4 weeks ago #43

$BABA this is a pure example how the market can be wrong, this company should go head to head with Amazon and be priced so cheap, take advantage.

Zeev Bovan DHT 4 weeks ago #45

$DHT long-term indicators remain favorable. The company maintains highly lucrative profit margins, an impressive forward dividend yield hovering around 20% ($4.88 annualized), and a secure technical management framework that positions it well ahead of its next official earnings report on 4 November 2026

Zeev Bovan DHT 4 weeks ago #46

$DHT long-term indicators remain favorable. The company maintains highly lucrative profit margins, an impressive forward dividend yield hovering around 20% ($4.88 annualized), and a secure technical management framework that positions it well ahead of its next official earnings report on 4 November 2026

Zeev Bovan TARA 4 weeks ago #47

Things are moving in the right direction, when this stock is traded at 26-30$ who will care that it was dirt cheap today. $TARA

Zeev Bovan TARA 4 weeks ago #48

$TARA Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Protara Therapeutics
October 15, 2026 08:00 ET

Little shaking and they be running lol

Zeev Bovan ORCL 4 weeks ago #49

Smart investors are loading up, there will come a time when $ORCL will be worth north of a 1000$ and those who accumulate today will laugh at the past and enjoy thier future.

Zeev Bovan TARA 1 month ago #50

$TARA those who are afraid to lose don’t deserve win. Once they get FDA approval they will reach analyst target price and it will just be the beginning of something bigger.